Zacks Investment Research on MSN
Here's why you should retain Masimo stock in your portfolio now
Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for innovative technology and research and development (R&D) efforts. The optimism, ...
Zacks Investment Research on MSN
Owlet vs. Masimo: Which medical monitoring stock is the better buy?
Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by ...
The medical technology specialist, known for its monitoring devices, named an interim CEO. This followed the resignation of its existing chief. Masimo announced that its CEO Joe Kiani informed the ...
In recent trading, shares of Masimo Corp. (Symbol: MASI) have crossed above the average analyst 12-month target price of $166.28, changing hands for $169.12/share. When a stock reaches the target an ...
Masimo ( (MASI)) just unveiled an announcement. On January 12, 2026, Masimo announced select preliminary financial results for the fourth quarter and full year 2025, ahead of its full earnings release ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results